Skip to main content
. 2006 Apr 19;2006(2):CD001387. doi: 10.1002/14651858.CD001387.pub2

1.8. Analysis.

1.8

Comparison 1 Ipratropium bromide versus short acting beta‐2 agonist via nebuliser or MDI, Outcome 8 Number of subjects with medication related adverse events.